THE RNA PRINTER
LIVE

Serial Number

97229623

Owner

CureVac Manufacturing GmbH

Attorney

Jennifer Fraser

Filing Date

Jan 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

THE RNA PRINTER Trademark

Serial Number: 97229623 • Registration: 7289725

THE RNA PRINTER is a trademark filed by CureVac Manufacturing GmbH on January 20, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CureVac Manufacturing GmbH (5 trademarks)

Friedrich-Miescher-Str. 15

Entity Type: 99

CUREVAC RNA PRINTER GMBH (4 trademarks)

FRIEDRICH-MIESCHER-STRASSE 15
TUBINGEN 72076 , DE

Entity Type: 27

Trademark Details

Filing Date

January 20, 2022

Registration Date

January 23, 2024

Goods & Services

(Based on 44(d) Priority Application) Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules

(Based on 44(e)) Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovacular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment of infectious diseases, allergies, autoimmune disorder and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparations, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Health care products, namely, bacterioligical, or bacterial, or vitamin, or sanitary preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements

(Based on 44(e)) Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes

(Based on 44(e)) Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders

(Based on 44(e)) Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical scientific testing of macromolecules

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 4, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jan 23, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Oct 18, 2023 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2023 CRFA
ASSIGNED TO LIE
Sep 27, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022 NWOS
NEW APPLICATION ENTERED
Jan 24, 2022 NWAP